Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22586815 | 1.00 | KDM4E (0.38) | KDM4EATML3MBTL1RXFP1MEN1 | |
| SCHEMBL22586771 | 0.97 | KDM4E (0.37) | KDM4EATML3MBTL1RXFP1 | |
| SCHEMBL22586353 | 0.97 | KDM4E (0.37) | KDM4EATML3MBTL1RXFP1 | |
| SCHEMBL22586352 | 0.95 | KDM4E (0.37) | KDM4EATML3MBTL1RXFP1 | |
| SCHEMBL22586350 | 0.95 | KDM4E (0.37) | KDM4EATML3MBTL1RXFP1 | |
| SCHEMBL22586814 | 0.94 | L3MBTL1 (0.35) | KDM4EATML3MBTL1RXFP1MEN1 | |
| SCHEMBL22586909 | 0.94 | L3MBTL1 (0.35) | KDM4EATML3MBTL1RXFP1MEN1 | |
| SCHEMBL23510299 | 0.94 | KDM4E (0.36) | KDM4EATML3MBTL1RXFP1 | |
| SCHEMBL23510338 | 0.94 | KDM4E (0.36) | KDM4EATML3MBTL1RXFP1 | |
| SCHEMBL22586820 | 0.94 | KDM4E (0.38) | KDM4EATML3MBTL1RXFP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230278992-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-07 | — | — | US | disclosed |
| US-20230278992-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-07 | — | — | US | disclosed |
| US-11718608-B2 | Organic molecules for use in optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-08 | — | — | US | disclosed |
| EP-3704210-B1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2022-02-09 | — | — | EP | disclosed |
| US-20200331898-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-10-22 | — | — | US | disclosed |
| EP-3476915-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-05-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718608-B2 | Organic molecules for use in optoelectronic devices | OR10J3, AOX1, ALDH1A2 | KDM4E 3834/4885ATM 3544/4885L3MBTL1 4093/4885 |
| US-20230278992-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, AOX1, ALDH1A2 | KDM4E 3938/4885ATM 3535/4885L3MBTL1 3914/4885 |
| US-20200331898-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, OPRM1, ORC3 | KDM4E 1821/4885ATM 3440/4885L3MBTL1 2755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.